Literature DB >> 23817433

Reproductive and hormonal factors, family history, and breast cancer according to the hormonal receptor status.

Valentina Rosato1, Cristina Bosetti, Eva Negri, Renato Talamini, Luigino Dal Maso, Matteo Malvezzi, Fabio Falcini, Maurizio Montella, Carlo La Vecchia.   

Abstract

The aim of this study was to investigate the association between breast cancer risk, reproductive factors, and family history of breast cancer by the estrogen receptor (ER) and progesterone receptor (PR) status. We analyzed data from an Italian case-control study including 1075 women with incident breast cancer and 1477 hospital controls. We estimated the odds ratios (ORs) of breast cancer using unconditional logistic regression models including major recognized risk factors for breast cancer. Stronger associations with ER+ than with ER- breast cancer were observed for parity (OR: 0.7 vs. 0.9 for ≥ 3 births vs. nulliparae), age at first birth (OR: 1.6 vs. 1.2 for age ≥ 30 vs. <25 years), menopausal status (OR: 0.7 vs. 0.8 for postmenopause vs. pre/perimenopause), age at menopause (OR: 1.3 vs. 1.2 for menopause at age ≥ 50 vs. <50 years), and family history of breast cancer (OR: 2.2 vs. 1.4). Among the ER+ patients, the presence of PR+ did not appreciably modify any of the risk estimates. The association with age at menarche and hormone replacement therapy use was neither significant nor heterogeneous across ER and PR subtypes. In conclusion, we found stronger associations with selected menstrual and reproductive factors for ER+ (PR+) than for ER- (PR-) breast cancers, though in the absence of significant heterogeneity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23817433     DOI: 10.1097/CEJ.0b013e3283639f7a

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  9 in total

Review 1.  Reproductive risk factors and breast cancer subtypes: a review of the literature.

Authors:  Kristin N Anderson; Richard B Schwab; Maria Elena Martinez
Journal:  Breast Cancer Res Treat       Date:  2014-01-30       Impact factor: 4.872

2.  Awareness That Breastfeeding Reduces Breast Cancer Risk: 2015-2017 National Survey of Family Growth.

Authors:  Adrienne Hoyt-Austin; Melanie S Dove; Renata Abrahão; Laura R Kair; Eleanor Bimla Schwarz
Journal:  Obstet Gynecol       Date:  2020-12       Impact factor: 7.623

3.  Breast cancer risk after full-term pregnancies among African women from Nigeria, Cameroon, and Uganda.

Authors:  Dominique Sighoko; Temidayo Ogundiran; Adeyinka Ademola; Clement Adebamowo; Lin Chen; Stella Odedina; Imaria Anetor; Paul Ndom; Antony Gakwaya; Oladosu Ojengbede; Dezheng Huo; Olufunmilayo I Olopade
Journal:  Cancer       Date:  2015-03-17       Impact factor: 6.860

4.  Adherence to cancer prevention guidelines in 18 African countries.

Authors:  Tomi F Akinyemiju; Jasmine A McDonald; Jennifer Tsui; Heather Greenlee
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

5.  Family history of breast and ovarian cancer and triple negative subtype in hispanic/latina women.

Authors:  Kristin Anderson; Patricia A Thompson; Betsy C Wertheim; Lorena Martin; Ian K Komenaka; Melissa Bondy; Adrian Daneri-Navarro; Maria Mercedes Meza-Montenegro; Luis Enrique Gutierrez-Millan; Abenaa Brewster; Lisa Madlensky; Malaika Tobias; Loki Natarajan; María Elena Martínez
Journal:  Springerplus       Date:  2014-12-11

6.  Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.

Authors:  Merete Ellingjord-Dale; Linda Vos; Steinar Tretli; Solveig Hofvind; Isabel Dos-Santos-Silva; Giske Ursin
Journal:  Breast Cancer Res       Date:  2017-01-23       Impact factor: 6.466

Review 7.  Risk Factors and Preventions of Breast Cancer.

Authors:  Yi-Sheng Sun; Zhao Zhao; Zhang-Nv Yang; Fang Xu; Hang-Jing Lu; Zhi-Yong Zhu; Wen Shi; Jianmin Jiang; Ping-Ping Yao; Han-Ping Zhu
Journal:  Int J Biol Sci       Date:  2017-11-01       Impact factor: 6.580

8.  The Impact of Reproductive Factors on the Risk of Breast Cancer by ER/PR and HER2: A Multicenter Case-Control Study in Northern and Eastern China.

Authors:  Fei Xie; Liyuan Liu; Houpu Yang; Miao Liu; Siyuan Wang; Jiajia Guo; Lixiang Yu; Fei Zhou; Fei Wang; Yujuan Xiang; Zhigang Yu; Shu Wang
Journal:  Oncologist       Date:  2022-02-03

Review 9.  Oral Contraceptive Use and Breast Cancer Risk According to Molecular Subtypes Status: A Systematic Review and Meta-Analysis of Case-Control Studies.

Authors:  Agnieszka Barańska; Joanna Dolar-Szczasny; Wiesław Kanadys; Wiktoria Kinik; Dorota Ceglarska; Urszula Religioni; Robert Rejdak
Journal:  Cancers (Basel)       Date:  2022-01-23       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.